Tuesday, October 9, 2012

KV Pharma & Compounding: We Told You So


“We have not made public the list of compounding pharmacies from whom our researchers acquired finished product samples. Nor do we know from which compounding pharmacies FDA acquired samples for its own testing,” he writes us. “What we do know is that the same facility that produced the compounded drug formulation which apparently led to the cases of meningitis makes and now is recalling 17p – a sterile injectable being used in women who are at high risk.”

To read Silverman's entire blog entry, click here.

No comments: